FindTrial
Sign In

Effect of Snehapurvak Siravedha in Grudhrasi with special reference to Sciatica

A Randomized Controlled Clinical Trial to Study the effect of Snehapurvak Siravedha in Grudhrasi with special reference to Sciatica - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072207
Enrollment
72
Registered
2024-08-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G55- Nerve root and plexus compressionsin diseases classified elsewhere

Interventions

None listed

Sponsors

Dr Akshaya Anil Toraskar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having classical signs and symptoms of Grudhrasi like PadaKramat Vedana, Toda, Pada suptata. Age between 30 years to 60 years. Patients having confirmed the diagnosis by using SLR test.

Exclusion criteria

Exclusion criteria: Patients with diabetes and cardiovascular disease, immunocompromised, traumatic, infective, neoplastic spine. Anemic patients with Hb less then 9. Pregnant women. Patients age below 30 years and above 60 years. Anatomical deformities like varus, vulgus, kyphosis, lordosis, scoliosis, spina bifida etc.

Design outcomes

Primary

MeasureTime frame
Reduction in signs and symptoms of GhrudhrasiTimepoint: 12 days—

Secondary

MeasureTime frame
where trial group is more effective than control group in reducing sign & symptoms of GrudhrasiTimepoint: 18 months—

Countries

India

Contacts

Public ContactDr Akshaya Anil Toraskar

SMBT Ayurved College and Hospital Nandi Hills Dhamangaon Igatpuri Nashik

rashmikurawar@gmail.com8793655354

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026